John is a health content expert and wellness researcher with a passion for preventative medicine and holistic lifestyle habits. Known for his ability to make intricate health topics easy to digest, John focuses on providing scientifically grounded insights that help readers take control of their long-term well-being. When he isn't researching the latest in clinical wellness, he is exploring the intersection of technology and human performance.
Researchers have launched a first-in-human trial using laser-activated therapy to target pancreatic cancer. Discover how this innovative technique works.
The PDUFA reauthorization is a critical opportunity for the FDA to modernize clinical trials. Explore the potential for policy reform and patient impact.
Acclinate is evolving its clinical trial diversity strategy by leveraging advanced data analytics to ensure more equitable and representative research.
AbelZeta secures FDA clearance for a Phase 1b/2 trial of C-CAR168, a CAR-T cell therapy targeting progressive multiple sclerosis. Learn about the implications.
Phio Pharmaceuticals advances PH-762 for cutaneous squamous cell carcinoma following a key FDA filing to support the next stage of clinical development.
Pasithea Therapeutics shares early clinical data from its latest drug pipeline. Explore the potential implications for neurological and psychiatric care.